miR-16 is a tumor suppressor in progestin-induced breast cancer

被引：0
|
作者：
Venturutti, Leandro [1 ]
Rivas, Martin A. [1 ]
Schillaci, Roxana [1 ]
Huang, Tim H-M [2 ]
Elizalde, Patricia V. [1 ]
机构：
[1] Inst Biol & Med Expt, RA-1428 Buenos Aires, DF, Argentina
[2] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-2305
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2305
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Chromosome 16 tumor-suppressor genes in breast cancer
    Rakha, EA
    Green, AR
    Powe, DG
    Roylance, R
    Ellis, IO
    GENES CHROMOSOMES & CANCER, 2006, 45 (06): : 527 - 535
  • [22] Non-canonical miRNA-RNA base-pairing impedes tumor suppressor activity of miR-16
    Quemener, Anais M.
    Bachelot, Laura
    Aubry, Marc
    Avner, Stephane
    Leclerc, Delphine
    Salbert, Gilles
    Cabillic, Florian
    Decaudin, Didier
    Mari, Bernard
    Mouriaux, Frederic
    Galibert, Marie-Dominique
    Gilot, David
    LIFE SCIENCE ALLIANCE, 2022, 5 (12)
  • [23] miR-202 acts as a potential tumor suppressor in breast cancer
    Gao, Shanshan
    Cao, Chunfang
    Dai, Qingfu
    Chen, Jian
    Tu, Jiancheng
    ONCOLOGY LETTERS, 2018, 16 (01) : 1155 - 1162
  • [24] Proliferation of endothelial and tumor epithelial cells by progestin-induced vascular endothelial growth factor from human breast cancer cells: Paracrine and autocrine effects
    Liang, YY
    Hyder, SM
    ENDOCRINOLOGY, 2005, 146 (08) : 3632 - 3641
  • [25] miR-15a and miR-16 supplementation as a potential remedy for ovarian cancer
    Chandran, P. Anoop
    Haeusler, Sebastian
    Wischhusen, Joerg
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S133 - S135
  • [26] Tumor Suppressor Mir-16 Mediates Trastuzumab Therapeutic Effects in Breast Cancer Via Its Novel Targets, Cyclin J (CCNJ) and Fuse Binding Protein 1 (FUBP1)
    Venturutti, Leandro
    Cordo Russo, Rosalia Inas
    Yankilevich, Patricio
    Oakley, Robert H.
    Huang, Tim H-M
    Schillaci, Roxana
    Cidlowski, John A.
    Virginia Elizalde, Patricia
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [27] Different signatures of miR-16, miR-30b and miR-93 in exosomes from breast cancer and DCIS patients
    Ni, Qingtao
    Stevic, Ines
    Pan, Chi
    Mueller, Volkmar
    Oliviera-Ferrer, Leticia
    Pantel, Klaus
    Schwarzenbach, Heidi
    SCIENTIFIC REPORTS, 2018, 8
  • [28] Different signatures of miR-16, miR-30b and miR-93 in exosomes from breast cancer and DCIS patients
    Qingtao Ni
    Ines Stevic
    Chi Pan
    Volkmar Müller
    Leticia Oliveira-Ferrer
    Klaus Pantel
    Heidi Schwarzenbach
    Scientific Reports, 8
  • [29] PROGESTIN-INDUCED FATTY-ACID SYNTHETASE IN BREAST-CANCER - FROM MOLECULAR-BIOLOGY TO CLINICAL-APPLICATIONS
    CHALBOS, D
    JOYEUX, C
    ESCOT, C
    GALTIER, F
    ROCHEFORT, H
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 595 : 67 - 73
  • [30] HIF-1\#945; is required for both progestin-induced VEGF secretion by breast cancer cells and in vivo progression of progestin-dependent mammary tumors
    Carroll, Candace
    Benakanakere, Indira
    Besch-Williford, Cynthia
    Liang, Yayun
    Hyder, Salman
    CANCER RESEARCH, 2009, 69
12345